Netala et al. [34] provided a comprehensive review on the management of cardiovascular diseases (CVDs), emphasising the role of cardiac biomarkers such as cTnI, CK-MB, IL-6, and TNF-α in diagnosing and monitoring CVD progression. This evidence concerns the gene TNF and cardiovascular disorder.